HealthTech180
HealthTech180 is a Barcelona-based healthcare venture builder and strategic advisory firm that partners with European university TTOs to source, diligence, and build life sciences ventures, currently holding five portfolio companies across hemostasis, telemedicine, and immunology.
- Company typePrivate
- Founded2019
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingServices
What HealthTech180 does
HealthTech180 is a Barcelona-based venture building and strategic advisory firm founded in 2019 that operates in the European healthcare innovation market. The firm partners with Technology Transfer Offices (TTOs) and Innovation Liaison Offices (ILOs) at top European universities to source early-stage healthcare technologies in areas of high unmet medical need, then applies an in-house venture building model that combines in-depth due diligence, licensing and IP strategy, and structured corporate finance support. HealthTech180's core offering is professional services and equity participation, not proprietary technology products; revenue is generated through advisory mandates, venture building equity, and licensing negotiation support, with no publicly disclosed pricing or fee structure.
The firm maintains a small core team (1–10 employees per stated headcount, including Managing Partner Nicolas Saglio and Partner Jean-Michel Terme) augmented by approximately 16 senior advisors spanning medical, scientific, finance, and commercial disciplines. Its network of senior advisors includes former VPs and executives from Novo Nordisk, AstraZeneca, Sanofi, Lundbeck, and Mallinckrodt, along with investment banking alumni from Goldman Sachs, Morgan Stanley, Deutsche Bank, Citi, and Macquarie, and senior academic clinicians from Vall d'Hebron, University of Perugia, and UT Health Houston. HealthTech180 has built and invested in five portfolio companies — Hemostatics, Abi Global Health (a B2B2C telemedicine platform operating in 35 countries), 30 Technology, Exostatics, and Stealth Immuno — and maintains strategic partnerships with abg Intellectual Property and CIMA Centro de Investigación Médica Aplicada. Its go-to-market is sales-led, relying on direct outreach, university TTO/ILO relationships, conference participation, and personal networks of team members to source deals and connect them to its cross-stage investor base spanning Business Angels, Family Offices, HNWIs, VCs, PE firms, and Corporate Venture arms.
HealthTech180 firmographics
Firmographics- Name
- HealthTech180
- Legal name
- HealthTech180
- Website
- https://healthtech180.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- HealthTech180 is a Barcelona-based healthcare venture builder and strategic advisory firm that partners with European university TTOs to source, diligence, and build life sciences ventures, currently holding five portfolio companies across hemostasis, telemedicine, and immunology.
- Ownership category
- akta.pro rank
HealthTech180 industry classification
Industry- Product category
- Healthcare Venture Advisory
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
- akta.pro secondary industries
- API Management & Developer Portals for Health Data (HLACABAD), Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)
Keywords
Where HealthTech180 is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
HealthTech180 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Strategic Advisory and Consulting Services: Revenue is generated through advisory mandates supporting healthcare technology ventures through the innovation-to-market process. Services include venture building, licensing negotiation, intellectual property strategy, and corporate finance advisory connecting companies to various levels of investors from early-stage to late-stage funding.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
HealthTech180 product offering
Product offeringCore offering
HealthTech180 is a venture building and strategic advisory firm that partners with European university Technology Transfer Offices (TTOs) and Innovation Liaison Offices (ILOs) to scout, validate, build, and fund innovative healthcare technologies. It provides tech scouting, venture building, funding and M&A advisory, and licensing and scaling services, and holds equity investments in healthcare ventures such as Hemostatics, Abi Global Health, 30 Technology, Exostatics, and Stealth Immuno.
Product overview
HealthTech180 is a healthcare venture building and innovation advisory company that does not offer traditional software products. The company provides services in technology scouting, venture building, funding and M&A advisory, and licensing and scaling support for healthcare innovations. Their portfolio includes investments in healthcare companies such as Hemostatics, Abi Global Health (30 Technology), Exostatics, and Stealth Immuno. The company operates by partnering with academia and industry to advance life-changing technologies from science bench to business success.
Differentiator
Problem solved
Functional benefit
Products and services
- Tech Scouting and Venture Building Services
- Funding and M&A Advisory Services
- Licensing and Scaling Advisory Services
Companies that use HealthTech180
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
HealthTech180 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
HealthTech180 partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- abg Intellectual Propertycoreabg Intellectual Property is a partner providing intellectual property services and support for HealthTech180's portfolio companies and ventures. Their logo appears in the partners section of the HealthTech180 website.
- CIMA Centro de Investigación Médica AplicadacoreCIMA (Centro de Investigación Médica Aplicada) at Clínica Universidad de Navarra is a medical research center that partners with HealthTech180 for innovation and entrepreneurship initiatives in healthcare.
- HemostaticscoreHemostatics is a portfolio company in which HealthTech180 has invested as part of their venture building activities. It appears on the Current Healthcare Investments section of the website.
- Abi Global HealthcoreAbi Global Health is a portfolio company and B2B2C telemedicine platform operating across 35 countries. Co-founded by HealthTech180 Senior Advisor Kim-Frederik Schneider. The company delivers health services to insurance, pharmaceutical, and consumer health companies.
- 30 Technologycore30 Technology is a portfolio company in which HealthTech180 has invested as part of their venture building activities. It appears on the Current Healthcare Investments section of the website.
- ExostaticscoreExostatics is a portfolio company in which HealthTech180 has invested as part of their venture building activities. It appears on the Current Healthcare Investments section of the website.
- Stealth ImmunocoreStealth Immuno is a portfolio company in which HealthTech180 has invested as part of their venture building activities. It appears on the Current Healthcare Investments section of the website.
Scale indicators3 records
Expansion highlights5 records
HealthTech180 competitors and assessment
Company assessmentDirect peers
- HealthCap: Swedish life sciences venture capital firm investing across European healthcare innovation. Comparable to HealthTech180 in its Northern/Continental European deal sourcing and biotech-heavy portfolio.
- Andera Partners: Paris-based private equity and venture capital firm with a dedicated life sciences practice. Comparable to HealthTech180 in its European healthcare investment focus and stage-agnostic approach.
- Forbion: Dutch life sciences venture capital firm investing across biotech and healthcare. Comparable to HealthTech180 in its European healthcare investment thesis and focus on advancing academic and early-stage innovation into commercial development.
- Novo Seeds: Early-stage healthcare venture arm of Novo Holdings investing in biotech and pharma. Comparable to HealthTech180's venture building approach at the earliest stages of company formation.
- BioGeneration Ventures (BGV): Dutch venture capital firm focused on early-stage European life sciences and biotech. Directly comparable to HealthTech180 in its early-stage European biotech thesis and academic spin-out orientation.
- Medicxi: European healthcare-focused venture capital firm based in London/Geneva that invests in early-stage life sciences assets. Highly comparable to HealthTech180 in its healthcare-only thesis and European academic deal sourcing, though Medicxi operates with significantly larger fund capital.
- Kurma Partners: Paris-based healthcare venture capital firm investing in European biotech and digital health. Comparable to HealthTech180 in its European healthcare-only focus and stage-agnostic approach from seed to growth.
- Apollo Therapeutics: UK-based translational healthcare venture firm originating from university research. Directly comparable to HealthTech180's model of bridging academic research from top universities (Cambridge, Imperial, UCL) into investable biotech companies.
- Vesalius Biocapital: Luxembourg-based venture capital firm specializing in European life sciences investments. Comparable to HealthTech180 in its pan-European healthcare thesis and early-to-mid-stage investment focus.
Regional players
- Locust Walk: US-based healthcare transaction advisory firm specializing in M&A and licensing for life sciences companies. Comparable to HealthTech180 in its healthcare-focused advisory mandate, though it serves a different (primarily US) geography and a larger client base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
HealthTech180 social profiles
Digital presenceHealthTech180 financial estimates
Financial estimateRevenue estimate
Valuation estimate
HealthTech180 leadership team
Management profileNumber of profiles
Profiles21 records
HealthTech180 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HealthTech180 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HealthTech180
What does HealthTech180 do?
HealthTech180 is a venture building and strategic advisory firm that partners with European university Technology Transfer Offices (TTOs) and Innovation Liaison Offices (ILOs) to scout, validate, build, and fund innovative healthcare technologies. It provides tech scouting, venture building, funding and M&A advisory, and licensing and scaling services, and holds equity investments in healthcare ventures such as Hemostatics, Abi Global Health, 30 Technology, Exostatics, and Stealth Immuno.
Is HealthTech180 a public or private company?
HealthTech180 is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was HealthTech180 founded?
HealthTech180 was founded in 2019. It employs 1 to 10 people.
Where is HealthTech180 based?
HealthTech180 is headquartered in Barcelona, Spain, in the Europe region.
How does HealthTech180 make money?
One revenue line is on record: strategic Advisory and Consulting Services.
Who are HealthTech180's main competitors?
Direct peers on record are HealthCap, Andera Partners, Forbion, Novo Seeds, BioGeneration Ventures (BGV), Medicxi, Kurma Partners, Apollo Therapeutics and Vesalius Biocapital. Locust Walk is listed as a regional player.
Does HealthTech180 have an API?
No public API is recorded for HealthTech180.
What industry is HealthTech180 in?
HealthTech180's product category is Healthcare Venture Advisory. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLACABAD, API Management & Developer Portals for Health Data. Its NAICS code is 541714 and its SIC code is 8000.